Key result
The EVOQUE transcatheter tricuspid valve replacement system offers a minimally invasive alternative for tricuspid regurgitation in high-risk orthotopic heart transplant recipients.
EVOQUE transcatheter tricuspid valve replacement is presented as a minimally invasive alternative for treating tricuspid regurgitation in high-risk orthotopic heart transplant recipients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Menda et al. (2026) studied this question. The EVOQUE transcatheter tricuspid valve replacement system offers a minimally invasive alternative for tricuspid regurgitation in high-risk orthotopic heart transplant recipients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: